Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@jax.org
Drug Name | ZL-1211 |
Trade Name | |
Synonyms | ZL 1211|ZL1211 |
Drug Descriptions |
ZL-1211 is a monoclonal antibody that targets CLDN18.2, potentially leading to antibody-dependent cellular cytotoxicity, activation of antitumor immune response, and inhibition of tumor growth (Cancer Res 2022;82(12_Suppl):Abstract nr 621). |
DrugClasses | CLDN18.2 Antibody 18 |
CAS Registry Number | NA |
NCIT ID | NA |
Therapy Name | Drugs | Efficacy Evidence | Clinical Trials |
---|---|---|---|
ZL-1211 | ZL-1211 | 0 | 1 |